Folinic Acid in Autism

• Status: Completed
• Trial end date: 2018-06-30
• Target enrollment: 0
• Participant gender: All

Summary

An examination of changes in urinary metabolites with use of folinic acid in children with autism spectrum disorder (ASD). Investigators will also measure behavioral measures and academic measures monthly at school with teachers and parents report.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, San Francisco
• Treatments: Folic Acid; Leucovorin; Levoleucovorin

Criteria

Inclusion Criteria:

• Between ages 5 and 25

Exclusion Criteria:

• Not currently taking folinic acid